“some patients have a very difficult time requiring multiple surgeries and have a life with chronic pain and chronic diarrhea. our current therapies, which are major advances, still only treat about 50 per cent of our patients,” he added. “when they work, they work great. when they don’t, it unfortunately can be very difficult. the main challenge is we still need to be able to improve our treatment, which is only going to come through better understanding of the actual underlying mechanisms. and i think that’s the future here. i see [the gem results] as a major step forward.”
“when you’re trying to focus on the inflammation, that fire has already started and we’re trying to put it out,” gastroenterologist dr. ken croitoru (pictured) of mount sinai hospital in toronto said. “so you have to get at the root of why the fire started.”
sinai health
the mount sinai team, in collaboration with researchers in the u.s., the u.k., israel, australia, new zealand and sweden, recruited 5,000 healthy children and siblings, like faber, of people with crohn’s disease over the past 15 years to look at their diet, immune function, intestinal barrier, gut bacteria, genetics and environment. after initial testing, participants were followed with a check-in every six months to see if they developed crohn’s disease.
more than 100 participants have developed crohn’s, allowing for a comparison of the initial samples taken when those participants were healthy with initial samples taken from participants who did not develop the disease. croitoru says the study design, called a prospective cohort study, provides an ideal window for scientists to examine what is different about those samples and determine possible disease triggers and development.